GDF-15 in plasma has previously been proposed as a biomarker in endometrial cancer [20], and has also been suggested as a serum biomarker in patients with prostate, pancreatic and colon cancers [13, 14, 16]. This evidence concerns the gene GDF15 and endometrial cancer.